The document discusses the pathogenesis of bacterial infection, including how bacteria interact with the host and cause disease. It describes factors that determine bacterial virulence like toxins, invasiveness, and the ability to evade the immune system. The document outlines Koch's postulates for determining the causative agent of a disease and notes exceptions where these postulates do not always apply. It also summarizes some key terms used in pathogenesis like infection, pathogenicity, and virulence factors. Specific examples of bacterial toxins that contribute to disease are discussed.
Pathogenesis of microbial infections dr. ihsan alsaimarydr.Ihsan alsaimary
Dr. ihsan edan abdulkareem alsaimary
PROFESSOR IN MEDICAL MICROBIOLOGY AND MOLECULAR IMMUNOLOGY
ihsanalsaimary@gmail.com
mobile : 009647801410838
university of basrah - college of medicine - basrah -IRAQ
This document discusses infection and infectious diseases. It defines key terms like infection, disease, pathogens, and commensals. It describes how infections are classified, including primary vs secondary infections. It outlines various sources of infection like humans, animals, insects, soil/water, and food. It also explains different methods of transmitting infections, such as contact, inhalation, ingestion, and inoculation.
This document discusses the mechanisms of bacterial pathogenesis. It defines key terms like commensal, opportunistic pathogen, pathogen, virulence, infection, and portal of entry. It describes bacterial virulence factors such as capsules, adhesins, invasiveness, exoenzymes, and toxins. It also discusses concepts like infecting dose, clinical manifestations, and the evolution of infection.
The document discusses various types of relationships between microorganisms such as mutualism, parasitism, and commensalism. It also defines key microbiology terms like infection, disease, pathogenicity, and virulence. Finally, it describes the different microorganisms that normally reside on or inside the human body as well as those that can be present transiently.
This document discusses various concepts related to bacterial infection and virulence factors. It begins by defining key terms like infection, disease, signs and symptoms. It then describes the different types of hosts and modes of transmission of infectious agents. It discusses the concepts of reservoirs, carriers and zoonotic infections. The major sections cover the epidemiology of infections, modes of transmission including direct and indirect, and routes of entry of pathogens. The last section provides details on various bacterial virulence factors that enhance pathogenicity like adherence factors, invasion factors, toxins and mechanisms of biofilm formation.
The document discusses various topics related to infection and immunity. It defines infection, types of infection, sources of infection, and modes of transmission. It also defines and classifies different types of infections such as focal infection, cross infection, and nosocomial infection. The document then discusses the sources of infection in humans including endogenous sources like carriers and exogenous sources like animals, insects, soil, water, and food. It also discusses routes of transmission of pathogens like contact, inhalation, ingestion, inoculation, and congenital transmission. The document defines pathogenicity and virulence factors in microbes. It then defines immunity and discusses the immune system including innate immunity provided by first line defenses and adaptive immunity provided by antibodies and
1. There are several differences between exotoxins and endotoxins as virulence factors produced by bacteria. Exotoxins are heat-labile proteins that are released from bacteria, while endotoxins are heat-stable lipopolysaccharides that remain part of the bacterial cell wall. Exotoxins have specific tissue targets and actions, while endotoxins cause non-specific effects.
2. A nosocomial infection refers to a hospital-acquired infection obtained from a healthcare setting.
3. An epidemic occurs when an infectious disease spreads rapidly among many individuals in a community or region. An endemic disease
This document provides an overview of epidemiology and the epidemiology of communicable diseases. It defines epidemiology as the study of disease distribution and determinants in populations. Communicable diseases are transmitted from one case to another through various cycles and modes of transmission. The epidemiologic triad of agent, host, and environment influences disease occurrence. Epidemic investigation aims to identify the infectious agent, affected individuals, and factors propagating an epidemic in order to control disease spread. Prevention strategies include primordial prevention by promoting healthy behaviors, and primary prevention targeting specific diseases.
Pathogenesis of microbial infections dr. ihsan alsaimarydr.Ihsan alsaimary
Dr. ihsan edan abdulkareem alsaimary
PROFESSOR IN MEDICAL MICROBIOLOGY AND MOLECULAR IMMUNOLOGY
ihsanalsaimary@gmail.com
mobile : 009647801410838
university of basrah - college of medicine - basrah -IRAQ
This document discusses infection and infectious diseases. It defines key terms like infection, disease, pathogens, and commensals. It describes how infections are classified, including primary vs secondary infections. It outlines various sources of infection like humans, animals, insects, soil/water, and food. It also explains different methods of transmitting infections, such as contact, inhalation, ingestion, and inoculation.
This document discusses the mechanisms of bacterial pathogenesis. It defines key terms like commensal, opportunistic pathogen, pathogen, virulence, infection, and portal of entry. It describes bacterial virulence factors such as capsules, adhesins, invasiveness, exoenzymes, and toxins. It also discusses concepts like infecting dose, clinical manifestations, and the evolution of infection.
The document discusses various types of relationships between microorganisms such as mutualism, parasitism, and commensalism. It also defines key microbiology terms like infection, disease, pathogenicity, and virulence. Finally, it describes the different microorganisms that normally reside on or inside the human body as well as those that can be present transiently.
This document discusses various concepts related to bacterial infection and virulence factors. It begins by defining key terms like infection, disease, signs and symptoms. It then describes the different types of hosts and modes of transmission of infectious agents. It discusses the concepts of reservoirs, carriers and zoonotic infections. The major sections cover the epidemiology of infections, modes of transmission including direct and indirect, and routes of entry of pathogens. The last section provides details on various bacterial virulence factors that enhance pathogenicity like adherence factors, invasion factors, toxins and mechanisms of biofilm formation.
The document discusses various topics related to infection and immunity. It defines infection, types of infection, sources of infection, and modes of transmission. It also defines and classifies different types of infections such as focal infection, cross infection, and nosocomial infection. The document then discusses the sources of infection in humans including endogenous sources like carriers and exogenous sources like animals, insects, soil, water, and food. It also discusses routes of transmission of pathogens like contact, inhalation, ingestion, inoculation, and congenital transmission. The document defines pathogenicity and virulence factors in microbes. It then defines immunity and discusses the immune system including innate immunity provided by first line defenses and adaptive immunity provided by antibodies and
1. There are several differences between exotoxins and endotoxins as virulence factors produced by bacteria. Exotoxins are heat-labile proteins that are released from bacteria, while endotoxins are heat-stable lipopolysaccharides that remain part of the bacterial cell wall. Exotoxins have specific tissue targets and actions, while endotoxins cause non-specific effects.
2. A nosocomial infection refers to a hospital-acquired infection obtained from a healthcare setting.
3. An epidemic occurs when an infectious disease spreads rapidly among many individuals in a community or region. An endemic disease
This document provides an overview of epidemiology and the epidemiology of communicable diseases. It defines epidemiology as the study of disease distribution and determinants in populations. Communicable diseases are transmitted from one case to another through various cycles and modes of transmission. The epidemiologic triad of agent, host, and environment influences disease occurrence. Epidemic investigation aims to identify the infectious agent, affected individuals, and factors propagating an epidemic in order to control disease spread. Prevention strategies include primordial prevention by promoting healthy behaviors, and primary prevention targeting specific diseases.
This document provides an overview of host-microbe relationships and disease processes. It defines key terminology related to pathology, infection, disease transmission, and clinical microbiology. It discusses Koch's postulates for establishing disease causation, different types of host-microbe interactions, and factors that influence disease patterns and spread. The document also outlines methods for isolating clinical samples, performing antimicrobial sensitivity testing, and interpreting minimum inhibitory concentration results.
The document discusses host-parasite relationships and pathogenicity of bacterial infections. It defines key terms like pathogens, opportunistic pathogens, carriers, infection, invasion, toxigenicity and virulence. It describes Koch's postulates for establishing the cause of infectious disease. It also discusses virulence factors of bacteria, types of toxins (exotoxins and endotoxins), examples of enzymes produced by bacteria, the normal flora of the human body, and host defense mechanisms against pathogens.
infection and infectious agents causing diseasesREKHA DEHARIYA
Microorganisms normally aid bodily functions but can cause disease if harmony is disrupted. An infection occurs when a pathogen enters the body, finds a favorable environment, and multiplies. An infection results in the pathogen colonizing the host and using its resources. A disease then results from impaired tissue function due to the pathogen or toxins it produces. Infections spread through a chain involving a reservoir, exit portal, transmission mode, entry portal, and susceptible host. Breaking any link in the chain prevents transmission.
This document defines key terminology related to microbial pathogenicity and discusses various concepts including:
1. It classifies microbes as saprophytes, parasites, commensals, and pathogens.
2. It describes the infection process and different types of infections such as primary, secondary, and nosocomial.
3. It explains mechanisms of microbial pathogenicity including routes of transmission, infective dose, evasion of host defenses, adhesion, invasion, and the role of toxins and pathogenicity islands.
Infectious diseases result from pathogenic microorganisms like viruses, bacteria, fungi and parasites. They can be transmitted between individuals through various pathways like physical contact. Non-infectious diseases have causes like genetic disorders, environmental factors and lifestyle choices. They cannot be transmitted between individuals. The immune system usually clears infections, resulting in immunity. However some pathogens can evade immunity and cause life-long infections like HIV.
This document discusses infectious and non-infectious diseases. It defines infectious diseases as clinically evident illnesses caused by pathogenic agents like viruses, bacteria, fungi, and parasites. These pathogens can be transmitted between hosts. Non-infectious diseases are not caused by pathogens and cannot be transmitted between individuals. The document covers causes of infectious diseases like primary pathogens and opportunistic infections. It also discusses immunity, classification of pathogens, and methods of proving infectious disease transmission like Koch's postulates. Non-infectious diseases are defined as not transmissible and caused by genetics, environment, lifestyle, or nutrition. Inherited genetic disorders and environmental factors that can lead to non-infectious diseases are outlined.
Diseases Caused by Viruses_ Khyati Gupta (1).pdfKhyatiGupta71
Viruses cause a variety of diseases that are transmitted through different routes. Common viral diseases include influenza, measles, mumps, rubella, smallpox, rabies, chikungunya, and dengue. Viruses have an incubation period before symptoms appear. Symptoms vary depending on the virus but can include fever, rash, joint pain, and respiratory issues. Some viral diseases may lead to severe complications affecting organs like the heart, brain, or CNS. Antiviral drugs and vaccines exist for some viruses.
This document defines and discusses various types of infections. It begins by defining an infection as the invasion of an organism's tissues by pathogenic agents, their multiplication, and the host's reaction. Infections can be caused by viruses, viroids, prions, bacteria, nematodes, arthropods, fungi, and other microorganisms. The document then provides details on the causes, signs and symptoms, diagnosis, prevention, and treatment of infections.
presentation about the communicable diseases (TB,malaria,filaria,leprosyand AIDS) their causative organs,prevention factors causes these diseases are clearly explained in these slides..
Microorganisms can cause disease when they enter the body and find a favorable environment. An infection occurs through a chain of events - a pathogen must have a reservoir, exit the reservoir, be transmitted to a new host, enter through a portal, and find a susceptible host. Breaking any link in the chain can prevent transmission and infection. Common ways to do this include proper hygiene, sterilization, use of antiseptics, vaccination, and strengthening a host's defenses.
1. CDC - Introduction to communicable disease control.pdfAderawAlemie
This document discusses communicable disease control and classification. It begins by introducing common communicable diseases in Ethiopia like tuberculosis, malaria, measles, and more. It then classifies diseases based on time course (acute vs chronic) and cause (infectious vs non-infectious). The majority of common diseases in Ethiopia and other parts of Africa are communicable due to person-to-person or animal-to-person transmission. The document outlines the chain of disease transmission from infectious agent, reservoir, port of exit, means of transmission, port of entry, and susceptible host.
The document outlines the chain of infection, which describes the process by which an infectious disease is transmitted. It begins with the infectious agent leaving a reservoir, passing through a portal of exit, being transmitted via a mode of transmission, entering through a portal of entry to infect a susceptible host. The document then defines each link in more detail, including infectious agents, reservoirs, carriers, periods of communicability, and modes of transmission. It provides examples to illustrate key concepts around how infectious diseases are able to spread.
Introduction of medical microbiology unit 1meghashridhar
This document provides an introduction to medical microbiology. It defines key terms related to bacteriology, virology, parasitology, mycology, and immunology. The history of microbiology is discussed, focusing on pioneers like Van Leeuwenhoek, Pasteur, Koch, Ehrlich, Lister, and Fleming. The relationship between microbes and hosts is explained, including normal flora, pathogens, opportunistic pathogens, and virulence. The transmission of infection is summarized, covering portals of entry/exit and means of transmission. The process of pathogenesis is outlined.
The document discusses infectious diseases, which are clinically evident illnesses caused by pathogenic agents like viruses, bacteria, fungi, or parasites. These diseases can be transmitted between individuals through various pathways like physical contact or contaminated objects. Non-infectious diseases are also discussed, which are not caused by pathogens and cannot be transmitted between people. They may be due to genetic, environmental, or lifestyle factors.
Module 5 Case Assignment Pertussis (Whooping Cough)TasksPart .docxadelaidefarmer322
Module 5 Case Assignment:
Pertussis (Whooping Cough)
Tasks
Part A: In one page maximum
Briefly describe the disease: Pertussis in terms of its infectivity, pathogenicity, and virulence.
Identify any reservoir(s), and mode(s) of transmission
Part B: (1-2 pages)
Weighing the benefits and the risks, take a clear position on whether you feel vaccination programs for Pertussis (whooping cough) should be expanded in your current community. Explain factors that went into your decision.
HELPING REFERENCES
U.S. Food & Drug Administration, Center for Food Safety & Applied Nutrition (n.d.) Bad Bug Book. Retrieved February 21, 2013 from
http://www.fda.gov/Food/FoodSafety/FoodborneIllness/FoodborneIllnessFoodbornePathogensNaturalToxins/BadBugBook/default.htm
FAO. Epidemiology: some basic concepts and definitions. Retrieved February 21, 2013 from
http://www.fao.org/wairdocs/ILRI/x5436E/x5436e04.htm
Centers for Disease Control and Prevention (2004). How to Investigate an Outbreak. Retrieved February 21, 2013 from
http://www.cdc.gov/excite/classroom/outbreak/steps.htm
Aschengrau A, Seage GR (2003). Chapter 6: Overview of Epidemiologic Study Designs. Essentials of Epidemiology in Public Health, Boston: Jones & Bartlett Publishers. Retrieved February 21, 2013 at:
http://publichealth.jbpub.com/aschengrau/Aschengrau06.pdf
Cosio G (2005). Epidemiological Overview of Tuberculosis [Presentation]. Retrieved February 21, 2013 from
www.paho.org/cdmedia/dpccd01/Presentations/Day1/EPIDEMIOLOGICAL%20OVERVIEW%20OF%20TUBERCULOSIS%202.ppt
Optional Readings
Long SG, DuPont HL, Gaul L, Arafat RR, Selwyn BJ, Rogers J, et al. (2007). Pulsed-field gel electrophoresis for
Salmonella
infection surveillance, Texas, USA. Emerg Infect Dis [serial on the Internet]. Retrieved fro
http://www.cdc.gov/EID/content/16/6/983.htm
READ:
Variations in Severity of Illness
The severity of an illness may be measured by the case fatality rate or the proportion of surviving patients with complications. The
case fatality rate
is defined as the number of deaths from a particular disease divided by the number of clinically apparent cases of that disease.
An infectious disease may have a wide variety of clinical symptoms, ranging from no symptoms to severe clinical illness or death. Diseases such as tuberculosis have a high proportion of asymptomatic individuals (low pathogenicity), while diseases such as measles have a high proportion of symptomatic infections and a small percent of severe or fatal illness. Diseases such as the African hemorrhagic fevers caused by Marburg and Ebola virus are very severe and usually fatal. For diseases with low pathogenicity, only a small fraction of cases are often diagnosed and reported. Control measures should be directed toward all infections capable of being transmitted to others, not just the symptomatic cases.
From a public health perspective, diseases of high incidence and lesser severity may be considered a more serious problem becaus.
Epidemiology, modes of transmission control of comm. disease pptSiddharthMendhe3
This document provides an overview of epidemiology and the control of communicable diseases. It defines epidemiology and describes the different types of infections and their modes of transmission. It discusses descriptive and analytical epidemiology. It also covers the normal flora of the human body, the infection process, and microbial virulence factors. Finally, it summarizes methods of controlling communicable diseases such as controlling the source of infection, blocking transmission routes, and protecting susceptible populations.
This document provides an overview of infectious diseases. It discusses that infectious diseases are caused by microorganisms like viruses, bacteria, fungi, and parasites. Landmark scientists like Louis Pasteur and Robert Koch established the germ theory of disease. Koch's postulates provide guidelines for identifying the microorganisms that cause specific diseases. While most microorganisms in the body are harmless symbionts, pathogens cause issues by destroying cells or releasing toxins. Infectious diseases spread through various methods like coughing/sneezing, physical contact, exchange of body fluids, contaminated water/food, or transmission from animals.
Microbe-Human Interactions: Infection and DiseaseMELVIN FAILAGAO
Chapter 12 Microbe-Human Interactions: Infection and Disease
subtopics:
1. The progress of an infection
2. Epidemiology: The study of disease in Populations
3. Non specific host defenses
4. Defense mechanisms of the host in perspective
The document defines various terminologies related to microbial pathogenicity and infection. It discusses terms like saprophytes, parasites, commensals, pathogens, opportunistic pathogens, infection, colonization, infestation, and more. It also classifies infections based on factors like source, clinical manifestation, epidemiological patterns, and more. Finally, it covers various mechanisms of microbial pathogenicity like adhesion, invasiveness, toxins, inhibition of phagocytosis, and more.
Pneumonia is a common lung infection that can be caused by bacteria, viruses, fungi or parasites. It results in inflammation and fluid in the alveoli, causing symptoms like cough, chest pain, fever and difficulty breathing. The most common bacterial causes are Streptococcus pneumoniae and atypical bacteria. Pneumonia poses greater risks for elderly people, young children, and those with weakened immune systems. Diagnosis involves tests like chest x-rays and treatment differs based on the identified cause.
This document provides an overview and guidelines for choosing antibiotics. It discusses collecting cultures before starting antibiotics and ensuring appropriate dosing. Common antibiotics are reviewed including beta-lactams like penicillins, cephalosporins, and carbapenems as well as quinolones, macrolides, and metronidazole. Specific coverage and cautions are highlighted. A case of possible osteomyelitis in a diabetic man with leg cellulitis is presented. Factors to consider when selecting antibiotics include patient history, location of infection, and likely pathogens.
This document provides an overview of host-microbe relationships and disease processes. It defines key terminology related to pathology, infection, disease transmission, and clinical microbiology. It discusses Koch's postulates for establishing disease causation, different types of host-microbe interactions, and factors that influence disease patterns and spread. The document also outlines methods for isolating clinical samples, performing antimicrobial sensitivity testing, and interpreting minimum inhibitory concentration results.
The document discusses host-parasite relationships and pathogenicity of bacterial infections. It defines key terms like pathogens, opportunistic pathogens, carriers, infection, invasion, toxigenicity and virulence. It describes Koch's postulates for establishing the cause of infectious disease. It also discusses virulence factors of bacteria, types of toxins (exotoxins and endotoxins), examples of enzymes produced by bacteria, the normal flora of the human body, and host defense mechanisms against pathogens.
infection and infectious agents causing diseasesREKHA DEHARIYA
Microorganisms normally aid bodily functions but can cause disease if harmony is disrupted. An infection occurs when a pathogen enters the body, finds a favorable environment, and multiplies. An infection results in the pathogen colonizing the host and using its resources. A disease then results from impaired tissue function due to the pathogen or toxins it produces. Infections spread through a chain involving a reservoir, exit portal, transmission mode, entry portal, and susceptible host. Breaking any link in the chain prevents transmission.
This document defines key terminology related to microbial pathogenicity and discusses various concepts including:
1. It classifies microbes as saprophytes, parasites, commensals, and pathogens.
2. It describes the infection process and different types of infections such as primary, secondary, and nosocomial.
3. It explains mechanisms of microbial pathogenicity including routes of transmission, infective dose, evasion of host defenses, adhesion, invasion, and the role of toxins and pathogenicity islands.
Infectious diseases result from pathogenic microorganisms like viruses, bacteria, fungi and parasites. They can be transmitted between individuals through various pathways like physical contact. Non-infectious diseases have causes like genetic disorders, environmental factors and lifestyle choices. They cannot be transmitted between individuals. The immune system usually clears infections, resulting in immunity. However some pathogens can evade immunity and cause life-long infections like HIV.
This document discusses infectious and non-infectious diseases. It defines infectious diseases as clinically evident illnesses caused by pathogenic agents like viruses, bacteria, fungi, and parasites. These pathogens can be transmitted between hosts. Non-infectious diseases are not caused by pathogens and cannot be transmitted between individuals. The document covers causes of infectious diseases like primary pathogens and opportunistic infections. It also discusses immunity, classification of pathogens, and methods of proving infectious disease transmission like Koch's postulates. Non-infectious diseases are defined as not transmissible and caused by genetics, environment, lifestyle, or nutrition. Inherited genetic disorders and environmental factors that can lead to non-infectious diseases are outlined.
Diseases Caused by Viruses_ Khyati Gupta (1).pdfKhyatiGupta71
Viruses cause a variety of diseases that are transmitted through different routes. Common viral diseases include influenza, measles, mumps, rubella, smallpox, rabies, chikungunya, and dengue. Viruses have an incubation period before symptoms appear. Symptoms vary depending on the virus but can include fever, rash, joint pain, and respiratory issues. Some viral diseases may lead to severe complications affecting organs like the heart, brain, or CNS. Antiviral drugs and vaccines exist for some viruses.
This document defines and discusses various types of infections. It begins by defining an infection as the invasion of an organism's tissues by pathogenic agents, their multiplication, and the host's reaction. Infections can be caused by viruses, viroids, prions, bacteria, nematodes, arthropods, fungi, and other microorganisms. The document then provides details on the causes, signs and symptoms, diagnosis, prevention, and treatment of infections.
presentation about the communicable diseases (TB,malaria,filaria,leprosyand AIDS) their causative organs,prevention factors causes these diseases are clearly explained in these slides..
Microorganisms can cause disease when they enter the body and find a favorable environment. An infection occurs through a chain of events - a pathogen must have a reservoir, exit the reservoir, be transmitted to a new host, enter through a portal, and find a susceptible host. Breaking any link in the chain can prevent transmission and infection. Common ways to do this include proper hygiene, sterilization, use of antiseptics, vaccination, and strengthening a host's defenses.
1. CDC - Introduction to communicable disease control.pdfAderawAlemie
This document discusses communicable disease control and classification. It begins by introducing common communicable diseases in Ethiopia like tuberculosis, malaria, measles, and more. It then classifies diseases based on time course (acute vs chronic) and cause (infectious vs non-infectious). The majority of common diseases in Ethiopia and other parts of Africa are communicable due to person-to-person or animal-to-person transmission. The document outlines the chain of disease transmission from infectious agent, reservoir, port of exit, means of transmission, port of entry, and susceptible host.
The document outlines the chain of infection, which describes the process by which an infectious disease is transmitted. It begins with the infectious agent leaving a reservoir, passing through a portal of exit, being transmitted via a mode of transmission, entering through a portal of entry to infect a susceptible host. The document then defines each link in more detail, including infectious agents, reservoirs, carriers, periods of communicability, and modes of transmission. It provides examples to illustrate key concepts around how infectious diseases are able to spread.
Introduction of medical microbiology unit 1meghashridhar
This document provides an introduction to medical microbiology. It defines key terms related to bacteriology, virology, parasitology, mycology, and immunology. The history of microbiology is discussed, focusing on pioneers like Van Leeuwenhoek, Pasteur, Koch, Ehrlich, Lister, and Fleming. The relationship between microbes and hosts is explained, including normal flora, pathogens, opportunistic pathogens, and virulence. The transmission of infection is summarized, covering portals of entry/exit and means of transmission. The process of pathogenesis is outlined.
The document discusses infectious diseases, which are clinically evident illnesses caused by pathogenic agents like viruses, bacteria, fungi, or parasites. These diseases can be transmitted between individuals through various pathways like physical contact or contaminated objects. Non-infectious diseases are also discussed, which are not caused by pathogens and cannot be transmitted between people. They may be due to genetic, environmental, or lifestyle factors.
Module 5 Case Assignment Pertussis (Whooping Cough)TasksPart .docxadelaidefarmer322
Module 5 Case Assignment:
Pertussis (Whooping Cough)
Tasks
Part A: In one page maximum
Briefly describe the disease: Pertussis in terms of its infectivity, pathogenicity, and virulence.
Identify any reservoir(s), and mode(s) of transmission
Part B: (1-2 pages)
Weighing the benefits and the risks, take a clear position on whether you feel vaccination programs for Pertussis (whooping cough) should be expanded in your current community. Explain factors that went into your decision.
HELPING REFERENCES
U.S. Food & Drug Administration, Center for Food Safety & Applied Nutrition (n.d.) Bad Bug Book. Retrieved February 21, 2013 from
http://www.fda.gov/Food/FoodSafety/FoodborneIllness/FoodborneIllnessFoodbornePathogensNaturalToxins/BadBugBook/default.htm
FAO. Epidemiology: some basic concepts and definitions. Retrieved February 21, 2013 from
http://www.fao.org/wairdocs/ILRI/x5436E/x5436e04.htm
Centers for Disease Control and Prevention (2004). How to Investigate an Outbreak. Retrieved February 21, 2013 from
http://www.cdc.gov/excite/classroom/outbreak/steps.htm
Aschengrau A, Seage GR (2003). Chapter 6: Overview of Epidemiologic Study Designs. Essentials of Epidemiology in Public Health, Boston: Jones & Bartlett Publishers. Retrieved February 21, 2013 at:
http://publichealth.jbpub.com/aschengrau/Aschengrau06.pdf
Cosio G (2005). Epidemiological Overview of Tuberculosis [Presentation]. Retrieved February 21, 2013 from
www.paho.org/cdmedia/dpccd01/Presentations/Day1/EPIDEMIOLOGICAL%20OVERVIEW%20OF%20TUBERCULOSIS%202.ppt
Optional Readings
Long SG, DuPont HL, Gaul L, Arafat RR, Selwyn BJ, Rogers J, et al. (2007). Pulsed-field gel electrophoresis for
Salmonella
infection surveillance, Texas, USA. Emerg Infect Dis [serial on the Internet]. Retrieved fro
http://www.cdc.gov/EID/content/16/6/983.htm
READ:
Variations in Severity of Illness
The severity of an illness may be measured by the case fatality rate or the proportion of surviving patients with complications. The
case fatality rate
is defined as the number of deaths from a particular disease divided by the number of clinically apparent cases of that disease.
An infectious disease may have a wide variety of clinical symptoms, ranging from no symptoms to severe clinical illness or death. Diseases such as tuberculosis have a high proportion of asymptomatic individuals (low pathogenicity), while diseases such as measles have a high proportion of symptomatic infections and a small percent of severe or fatal illness. Diseases such as the African hemorrhagic fevers caused by Marburg and Ebola virus are very severe and usually fatal. For diseases with low pathogenicity, only a small fraction of cases are often diagnosed and reported. Control measures should be directed toward all infections capable of being transmitted to others, not just the symptomatic cases.
From a public health perspective, diseases of high incidence and lesser severity may be considered a more serious problem becaus.
Epidemiology, modes of transmission control of comm. disease pptSiddharthMendhe3
This document provides an overview of epidemiology and the control of communicable diseases. It defines epidemiology and describes the different types of infections and their modes of transmission. It discusses descriptive and analytical epidemiology. It also covers the normal flora of the human body, the infection process, and microbial virulence factors. Finally, it summarizes methods of controlling communicable diseases such as controlling the source of infection, blocking transmission routes, and protecting susceptible populations.
This document provides an overview of infectious diseases. It discusses that infectious diseases are caused by microorganisms like viruses, bacteria, fungi, and parasites. Landmark scientists like Louis Pasteur and Robert Koch established the germ theory of disease. Koch's postulates provide guidelines for identifying the microorganisms that cause specific diseases. While most microorganisms in the body are harmless symbionts, pathogens cause issues by destroying cells or releasing toxins. Infectious diseases spread through various methods like coughing/sneezing, physical contact, exchange of body fluids, contaminated water/food, or transmission from animals.
Microbe-Human Interactions: Infection and DiseaseMELVIN FAILAGAO
Chapter 12 Microbe-Human Interactions: Infection and Disease
subtopics:
1. The progress of an infection
2. Epidemiology: The study of disease in Populations
3. Non specific host defenses
4. Defense mechanisms of the host in perspective
The document defines various terminologies related to microbial pathogenicity and infection. It discusses terms like saprophytes, parasites, commensals, pathogens, opportunistic pathogens, infection, colonization, infestation, and more. It also classifies infections based on factors like source, clinical manifestation, epidemiological patterns, and more. Finally, it covers various mechanisms of microbial pathogenicity like adhesion, invasiveness, toxins, inhibition of phagocytosis, and more.
Pneumonia is a common lung infection that can be caused by bacteria, viruses, fungi or parasites. It results in inflammation and fluid in the alveoli, causing symptoms like cough, chest pain, fever and difficulty breathing. The most common bacterial causes are Streptococcus pneumoniae and atypical bacteria. Pneumonia poses greater risks for elderly people, young children, and those with weakened immune systems. Diagnosis involves tests like chest x-rays and treatment differs based on the identified cause.
Similar to PATHOGENESIS_OF_BACTERIAL_INFECTION.pdf (20)
This document provides an overview and guidelines for choosing antibiotics. It discusses collecting cultures before starting antibiotics and ensuring appropriate dosing. Common antibiotics are reviewed including beta-lactams like penicillins, cephalosporins, and carbapenems as well as quinolones, macrolides, and metronidazole. Specific coverage and cautions are highlighted. A case of possible osteomyelitis in a diabetic man with leg cellulitis is presented. Factors to consider when selecting antibiotics include patient history, location of infection, and likely pathogens.
This document discusses various idiopathic interstitial pneumonias (IIPs), including their definitions, histological features, radiographic appearances, treatments, and prognoses. It covers common IIPs such as idiopathic pulmonary fibrosis (IPF), nonspecific interstitial pneumonia (NSIP), desquamative interstitial pneumonia (DIP), respiratory bronchiolitis-associated interstitial lung disease (RB-ILD), acute interstitial pneumonia (AIP), and cryptogenic organizing pneumonia (COP). Lung biopsy is an important tool to distinguish between IIPs and make treatment decisions, but larger tissue samples are often needed due to sampling errors with transbronchial biopsies
This document provides an overview of various infectious diseases caused by bacteria, viruses, mycetes, and parasites. It describes common bacterial infections from staphylococci, streptococci, pneumococci, neisseria, and more. It also summarizes viral diseases caused by DNA viruses including poxviruses, herpesviruses, adenoviruses, papovaviruses, and parvoviruses. The document provides detailed information on infectious disease symptoms, transmission routes, locations of infection in the body, and potential complications.
This document discusses antifungal drugs used to treat fungal infections. It covers several classes of antifungals including polyenes like amphotericin B and nystatin that damage fungal cell membranes, azoles like fluconazole and itraconazole that inhibit ergosterol synthesis, echinocandins like caspofungin that inhibit cell wall synthesis, and other antifungals such as flucytosine and allylamines. Each drug's mechanism of action, indications, dosage, administration route, efficacy, side effects, and drug interactions are described. The document provides an in-depth overview of antifungal drug properties and use in treating various fungal diseases
This document outlines plans for Phase II of the GNP (Good Nebulization Practice) program which aims to educate doctors, paramedics, patients, and chemists on best practices for nebulization. Key goals are to reach 2000 intensivists in ICUs, translate materials to regional languages for 10,000 doctors, and increase outreach to 5000 chemists. The Phase II plan includes expanding existing GNP clinic and kit services, launching regional language nebulization corners, meetings focused on scientific and practical aspects, and utilizing digital tools and video demonstrations. New and existing customers will be categorized and provided tailored education and resources to improve nebulization practices.
1) The document discusses how asthma management can provide great opportunities for family doctors and general practitioners to treat patients and grow their practices. Asthma is very common, affecting 1 in 10 patients, and most patients prefer treatment from their family doctor over a chest physician.
2) The key to a successful asthma practice is proper diagnosis, treatment, simplifying the treatment plan for patients, and effective communication. Proper diagnosis can usually be made with a focused history and examination. Treatment involves both reliever and controller medications, with inhaled corticosteroids being the most effective controller.
3) With the right approach, family doctors can treat asthma as effectively as chest physicians. Regular use of inhaled corticosteroids
For a diagnosed asthmatic patient presenting with breathlessness, the initial treatment would involve administering high doses of a rapid-acting inhaled bronchodilator like salbutamol every 20 minutes for the first hour. If the patient does not see adequate improvement, ipratropium bromide would be added. Systemic corticosteroids like prednisolone would also be prescribed if the exacerbation is severe or not responding to initial bronchodilator therapy, to reduce inflammation and control the attack.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...Donc Test
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Study Guide Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Course Hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Answers Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Course hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Study Guide Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Ebook Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Questions Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Stuvia
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
2. The pathogenesis of bacterial infection
includes the initiation of the infectious
process and the mechanisms leading to
the development of signs and symptoms
of bacterial disease.
The outcome of the interaction between
The outcome of the interaction between
bacteria and host is determined by
characteristics that favour establishment
of the bacteria within the host and their
ability to damage the host as they are
opposed by host defense mechanisms.
.
3. Among the characterics of bacteria
are adherence to host cells,
invasiveness, toxigenity, and ability to
evade the host s immune system.
If the bacteria or immunological
reactions injure the host sufficiently,
disease becomes apparent.
4. Pathogenesis
Pathogenesis
of
of bacterial
bacterial infection
infection
Humans and animals have abundant normal
microflora.
Most bacteria do not produce disease but
achieve a balance with the host that ensures
achieve a balance with the host that ensures
the survival, growth, and propagation of both
the bacteria and the host.
Sometimes bacteria that are clearly pathogens
(e.g. Salmonella typhi) are present, but infection
remains latent or subclinical and the host is a
"carrier" of the bacteria.
5. It can be difficult to show that a specific
bacterial species is the cause of a particular
disease.
In 1884, Robert Koch proposed a series of
postulates in his treatise on Mycobacterium
postulates in his treatise on Mycobacterium
tuberculosis and tuberculosis.
These postulates have been applied more
broadly to link many specific bacterial species
with particular diseases.
6. Koch
Koch s
s postulates
postulates are
are summarized
summarized as
as follows
follows:
:
The microorganism should be found in all cases of the
disease in question, and its distribution in the body
should be in accordance with the lesions observed.
The microorganism should be grown in pure culture in
vitro (or outsite the body of the host) for several
vitro (or outsite the body of the host) for several
generations.
When such a pure culture is inoculated into
susceptible animal species, the typical disease must
result.
The microorganism must again be isolated from the
lesions of such experimentally produced disease.
7. Koch
Koch s
s postulates
postulates remain
remain a
a
mainstay
mainstay of
of microbiology
microbiology
However
However,
, since
since the
the late
late 19th
19th century
century, many
, many
microorganisms
microorganisms that
that do not
do not meet
meet the
the criteria
criteria of
of
the
the postulates
postulates have
have been
been shown
shown to cause
to cause
disease
disease.
.
disease
disease.
.
For
For example
example,
, Treponema
Treponema pallidum
pallidum (
(syphilis
syphilis)
)
and
and Mycobacerium
Mycobacerium leprae
leprae (
(leprosy
leprosy)
) cannot
cannot be
be
grown
grown in
in vitro
vitro,
, but
but there
there are
are animal
animal models
models of
of
infection
infection with
with these
these agents
agents.
.
8. In
In another
another example
example,
, Neisseria
Neisseria gonorrhoeae
gonorrhoeae
(
(gonorrhea
gonorrhea),
), there
there is
is no
no animal
animal model
model of
of
infection
infection even
even though
though the
the bacteria
bacteria can
can readily
readily
be
be cultivated
cultivated in
in vitro
vitro.
.
The
The host
host s
s immune
immune responses
responses should
should be
be
considered
considered when
when an
an organism
organism is
is being
being
investigated
investigated as
as the
the possible
possible cause
cause of
of a
a disease
disease.
.
Thus
Thus,
, development
development of
of a
a rise
rise in
in specific
specific antibody
antibody
during
during recovery
recovery from
from disease
disease is
is an
an important
important
adjunct
adjunct to Koch
to Koch s
s postulates
postulates.
.
9. Modern
Modern-
-day
day microbial
microbial genetics
genetics has
has opened
opened new
new
frontiers
frontiers to study
to study pathogenic
pathogenic bacteria
bacteria and
and differentiate
differentiate
them
them from
from non
non-
-pathogens
pathogens.
.
The
The ability
ability to study
to study genes
genes associated
associated with
with virulence
virulence
has led to a
has led to a proposed
proposed of
of Koch
Koch´
´s
s postulates
postulates:
:
The phenotype, or property, under investigation
should be associated with pathogenic members of a
should be associated with pathogenic members of a
genus or pathogenic strains of a species.
Specific inactivation of the gene(s) associated with the
suspected virulence trait should lead to a measurable
loss in pathogenicity or virulence.
Reversion or allelic replacement of the mutated gene
should lead to restoration of pathogenicity.
10. Analysis
Analysis of
of infection
infection and
and disease
disease through
through the
the
application
application of
of principles
principles such as Koch
such as Koch s
s postulates
postulates
leads
leads to
to classification
classification of
of bacteria
bacteria as
as pathogenic
pathogenic or
or
non
non-
-pathogenic
pathogenic.
.
Some
Some bacterial
bacterial species are
species are always
always considered
considered to
to be
be
pathogens
pathogens,
, and
and their
their presence
presence is
is abnormal
abnormal.
.
–
– Examples
Examples include
include Mycobacterium
Mycobacterium tuberculosis
tuberculosis
–
– Examples
Examples include
include Mycobacterium
Mycobacterium tuberculosis
tuberculosis
(
(tuberulosis
tuberulosis)
) and
and Yersinia
Yersinia pestis
pestis (
(plague
plague).
).
–
– Other
Other species are
species are commonly
commonly part
part of
of the
the normal
normal flora
flora
of
of humans
humans (
(and
and animals
animals)
) but
but can
can also
also frequently
frequently
cause
cause disease
disease.
. For
For example
example,
, Escherichia
Escherichia coli
coli is
is part
part
of
of the
the gastrointestinal
gastrointestinal flora
flora of
of normal
normal humans
humans,
, but
but it
it
is
is also
also a
a comon
comon cause
cause of
of urinary
urinary tract
tract infection
infection,
,
traveller
traveller s
s diarrhea
diarrhea,
, and
and other
other diseases
diseases.
.
11. The
The infectious
infectious process
process
Infection
Infection indicates
indicates multiplication
multiplication of
of
microorganisms
microorganisms.
.
Prior to
Prior to multiplication
multiplication,
, bacteria
bacteria (in case
(in case of
of
bacterial
bacterial infection
infection)
) must
must enter
enter and
and establish
establish
bacterial
bacterial infection
infection)
) must
must enter
enter and
and establish
establish
themselves
themselves within
within the
the host.
host.
The
The most
most frequent
frequent portals
portals of
of entry
entry are
are the
the
respiratory
respiratory (
(mouth
mouth and
and nose),
nose), gastrointestinal
gastrointestinal,
,
and
and urogenital
urogenital tracts
tracts.
. Abnormal
Abnormal areas
areas of
of
mucous
mucous membranes
membranes and
and skin (
skin (e.g
e.g.
. cuts
cuts,
, burns
burns)
)
are
are also
also frequent
frequent sites
sites of
of entry
entry.
.
12. The
The infectious
infectious process
process
Once in the body, bacteria must attach or
adhere to host cells, usually epithelial cells.
After the bacteria have established a primary
site of infection, they multiply and spread.
Infection can spread directly through tissues or
via the lymphatic system to bloodstream.
Bloodstream infection (bacteremia) can be
transient or persistent. Bacteremia allows
bacteria to spread widely in the body and
permits them to reach tissues particularly
suitable for their multiplication.
13. The
The infectious
infectious process
process
As an example of the infectious process, Streptococcus
pneumoniae can be cultured from the nasopharynx of 5-40% of
healthy people.
Occasionally, S. pneumoniae strains from the nasopharynx are
aspirated into the lungs. Infection develops in the terminal air
space of the lungs in persons who do not have protective
antibodies against that type of S. pneumoniae. Multiplication of
antibodies against that type of S. pneumoniae. Multiplication of
S. pneumoniae strains and resultant inflammation lead to
pneumonia. The strains then enter the lymphatics of the lung
and move to the bloodstream. Between 10% and 20% of
persons with S. pneumoniae pneumonia have bacteremia at
the time the diagnosis of pneumonia is made. Once bacteremia
occurs, S. pneumoniae strains can spread to their preferred
secondary sites of infection (e.g. cerebrospinal fluid, heart
valves, joint spaces). The major resulting complications of S.
pneumoniae pneumonia include meningitis, endocarditis and
septic arthritis.
14. Basic terms frequently used in
describing aspects of pathogenesis:
Infection
–Multiplication of an infectious agent within the
body.
–Multiplication of the bacteria that are part of
–Multiplication of the bacteria that are part of
normal flora of gastrointestinal tract, skin, etc,
is generally not considered an infection.
–On the other hand, multiplication of
pathogenic bacteria (e.g. Salmonella
species), even if the person is asymptomatic,
is deemed an infection.
15. Basic terms frequently used in
describing aspects of pathogenesis:
Pathogenicity
– The ability of an infectious agent to cause disease.
Virulence
Virulence
– The quantitative ability of an agent to cause
disease.
– Virulent agents cause disease when introduced into
the host in small numbers.
– Virulence involves invasiveness and toxigenicity.
16. Basic terms frequently used in
describing aspects of pathogenesis:
Toxigenicity
– The ability of a microorganism to produce a toxin
that contributes to the development of disease.
Invasion
– The process whereby bacteria, parasites, fungi and
viruses enter the host cells or tissues and spread in
the body.
17. Basic terms frequently used in
describing aspects of pathogenesis:
Pathogen
– A microorganism capable of causing disease.
Non-pathogen
– A microorganism that does not cause disease. It may be part
– A microorganism that does not cause disease. It may be part
of the normal flora.
Opportunistic pathogen
– An agent capable of causing disease only when the host s
resistance is impaired (e.g. the patient is
immunocompromised).
– An agent capable of causing disease only when spread from
the site with normal bacterial microflora to the sterile tissue
or organ.
20. Endotoxins
Endotoxins of
of
gram
gram-
-negative
negative bacteria
bacteria
The endotoxins of gram-negative bacteria
are complex lipopolysaccharides derived
from bacterial cell walls and are often
from bacterial cell walls and are often
liberated when the bacteria lyse.
The substances are heat-stable and can
be extracted (e.g. with phenol-water).
21. Pathophysiological effects of
endotoxins are similar regardless
of their bacterial origin:
–fever
–leukopenia
–hypotension
–hypotension
–impaired organ perfusion and acidosis
–activation of C3 and complement cascade
–disseminated intravascular coagulation
(DIC)
–shock, death
22. Exotoxins
Many gram-positive and gram-
negative bacteria produce exotoxins
of considerable medical importance.
Some of these toxins have had major
role in world history (e.g. toxin of
Clostridium tetani).
23. Diphtheria toxin
(toxin of Corynebacterium diphtheriae)
Corynebacterium
Corynebacterium diphtheriae
diphtheriae strains
strains that
that
carry
carry a
a temperate
temperate bacteriophage
bacteriophage with
with the
the
structural
structural gene
gene for
for the
the toxin are
toxin are toxigenic
toxigenic
and
and produce
produce diphtheria
diphtheria toxin.
toxin.
and
and produce
produce diphtheria
diphtheria toxin.
toxin.
This
This native
native toxin
toxin is
is enzymatically
enzymatically
degraded
degraded into
into two
two fragments
fragments: A
: A and
and B,
B,
linked
linked together
together by a disulfide
by a disulfide bound
bound.
. Both
Both
fragments
fragments are
are necessary
necessary for
for toxin
toxin activity
activity.
.
24. Tetanospasmin (toxin of Clostridium tetani)
Clostridium
Clostridium tetani
tetani is
is an
an anaerobic
anaerobic gram
gram-
-positive rod
positive rod that
that is
is
widespread
widespread in
in the
the environment
environment.
.
Clostridium
Clostridium tetani
tetani contaminates
contaminates wounds
wounds,
, and
and the
the spores
spores
germinate
germinate in
in the
the anaerobic
anaerobic environment
environment of
of the
the devitalized
devitalized
tissue
tissue.
. The
The vegetative
vegetative forms
forms of
of Clostridium
Clostridium tetani
tetani produce
produce
tissue
tissue.
. The
The vegetative
vegetative forms
forms of
of Clostridium
Clostridium tetani
tetani produce
produce
toxin
toxin tetanospasmin
tetanospasmin.
. The
The released
released toxin has
toxin has two
two peptides
peptides
linked
linked by disulfide
by disulfide bounds
bounds. Toxin
. Toxin reaches
reaches the
the central
central
nervous
nervous system
system by
by retrograde
retrograde transport
transport along
along axons
axons and
and
through
through the
the systemic
systemic circulation
circulation.
. The
The toxin
toxin acts
acts by
by
blocking
blocking release
release of
of an
an inhibitory
inhibitory mediator
mediator in motor neuron
in motor neuron
synapses
synapses.
. The
The result
result is
is initially
initially localized
localized then
then generalized
generalized,
,
muscle
muscle spasms
spasms.
. Extremely
Extremely small
small amount
amount of
of toxin
toxin can
can be
be
lethal
lethal for
for humans
humans.
.
25. Botulotoxin (toxin of Clostridium botulinum)
Clostridium
Clostridium botulinum
botulinum is
is found
found in
in soil
soil or
or water
water and
and may
may
grow
grow in
in foods
foods if
if the
the environment
environment is
is appropriately
appropriately
anaerobic
anaerobic.
.
An
An exceedingly
exceedingly potent
potent toxin
toxin (
(the
the most
most potent
potent toxin
toxin known
known)
)
is
is produced
produced by
by Clostridium
Clostridium botulinum
botulinum strains
strains.
. It
It is
is heat
heat-
-
is
is produced
produced by
by Clostridium
Clostridium botulinum
botulinum strains
strains.
. It
It is
is heat
heat-
-
labile
labile and
and is
is destroyed
destroyed by
by sufficient
sufficient heating
heating.
. There
There are
are
eight
eight disctinct
disctinct serological
serological types
types of
of toxin
toxin.
. Types
Types A,
A, B
B and
and E
E
are
are most
most commonly
commonly associated
associated wih
wih human
human disease
disease.
. Toxin
Toxin
is
is absorbed
absorbed from
from the
the gut
gut and
and carried
carried to
to motor
motor nerves
nerves,
,
where
where it
it blocks
blocks the
the release
release of
of acetylcholine
acetylcholine at
at synapses
synapses
and
and neuromuscular
neuromuscular junctions
junctions.
. Muscle
Muscle contraction
contraction does
does not
not
occur
occur,
, and
and paralysis
paralysis results
results.
.
26. Toxins of
Clostridium perfringens
Spores
Spores of
of Clostridium
Clostridium perfringens
perfringens are
are introduced
introduced
into
into the
the wounds
wounds by
by contamination
contamination with
with soil
soil or
or
faeces
faeces. In
. In the
the presence
presence of
of necrotic
necrotic tissue
tissue (
(an
an
anaerobic
anaerobic environment
environment),
), spores
spores germinate
germinate and
and
vegetative
vegetative cells
cells produce
produce several
several different
different toxins
toxins.
.
vegetative
vegetative cells
cells produce
produce several
several different
different toxins
toxins.
.
Many
Many of
of these are
these are necrotizing
necrotizing and
and hemolytic
hemolytic and
and
favour
favour the
the spread
spread of
of gangrene
gangrene:
:
–
– alpha
alpha toxin
toxin is
is a
a lecithinase
lecithinase that
that damages
damages cell
cell
membranes
membranes
–
– theta
theta toxin
toxin also
also has a
has a necrotizing
necrotizing affect
affect
–
– and
and other
other
27. Streptococcal erythrogenic toxin
Some
Some strains
strains of
of hemolytic
hemolytic lysogenic
lysogenic
streptococci
streptococci produce
produce a toxin
a toxin that
that results
results in
in
a
a punctate
punctate maculopapular
maculopapular erythematous
erythematous
rash
rash, as in
, as in scarlet
scarlet fewer
fewer.
.
rash
rash, as in
, as in scarlet
scarlet fewer
fewer.
.
Production
Production of
of erythrogenic
erythrogenic toxin
toxin is
is under
under
the
the genetic
genetic control
control of
of temperate
temperate
bacteriophage
bacteriophage.
. If
If the
the phage
phage is
is lost
lost,
, the
the
streptococi
streptococi cannot
cannot produce
produce toxin.
toxin.
28. Toxic shock syndrom toxin - 1
(TSST-1)
Some
Some Staphylococcus
Staphylococcus aureus
aureus strains
strains growing
growing on
on
mucous
mucous membranes
membranes (
(e.g
e.g. on
. on the
the vagina in
vagina in
association
association with
with menstruation
menstruation),
), or
or in
in wounds
wounds,
,
elaborate
elaborate TSST
TSST-
-1.
1.
elaborate
elaborate TSST
TSST-
-1.
1.
This
This toxin
toxin is
is associated
associated with
with toxic
toxic shock
shock syndrome.
syndrome.
The
The illness
illness is
is characterized
characterized by
by shock
shock,
, high
high fewer
fewer,
,
and
and a
a diffuse
diffuse red
red rash
rash that
that later
later desquamates
desquamates,
,
multiple
multiple other
other organs
organs systems
systems are
are involved
involved as
as well
well.
.
29. Exotoxins associated with
diarrheal diseases
Vibrio
Vibrio cholerae
cholerae toxin
toxin
Staphylococcus
Staphylococcus aureus
aureus enterotoxin
enterotoxin
Other
Other enterotoxins
enterotoxins -
- enterotoxins
enterotoxins are
are also
also
produced
produced by
by some
some strains
strains of
of:
:
–
–Yersinia
Yersinia en
ent
terocolitica
erocolitica
–
–Vibrio
Vibrio parahaemolyticus
parahaemolyticus
–
–Aeromonas
Aeromonas species
species
30. Enzymes
Enzymes
Many species
Many species of
of bacteria
bacteria produce
produce enzymes
enzymes that
that are not
are not
intrinsically
intrinsically toxic
toxic but
but play
play important
important role in
role in the
the infectious
infectious
process
process.
.
Collagenase
Collagenase
–
– degrades
degrades collagen
collagen,
, the
the major protein
major protein of
of fibrous
fibrous
connective
connective tissue
tissue,
, and
and promotes
promotes spread
spread of
of infection
infection in
in
connective
connective tissue
tissue,
, and
and promotes
promotes spread
spread of
of infection
infection in
in
tissue
tissue.
.
Coagulase
Coagulase
–
– Staphylococccus
Staphylococccus aureus
aureus produce
produce coagulase
coagulase,
, which
which
works
works in
in conjuction
conjuction with
with serum
serum factors
factors to
to coagulate
coagulate
plasma.
plasma. Coagulase
Coagulase contributes
contributes to
to the
the formation
formation of
of fibrin
fibrin
walls
walls around
around staphylococcal
staphylococcal lesions
lesions,
, which
which helps
helps them
them
persist
persist in
in tissues
tissues.
.
31. Enzymes
Enzymes
Hyaluronidases
Hyaluronidases
–
– enzymes
enzymes that
that hydrolyze
hydrolyze hyaluronic
hyaluronic acid
acid, a
, a constituent
constituent of
of
the
the ground
ground substance
substance of
of connective
connective tissue
tissue.
. They
They are
are
produced
produced by
by many
many bacteria
bacteria (
(e.g
e.g.
. staphylococci
staphylococci,
,
streptococci
streptococci and
and anaerobes
anaerobes)
) and
and aid
aid in
in their
their spread
spread
through
through tissues
tissues.
.
Streptokinase
Streptokinase
–
– many
many hemolytic
hemolytic streptococci
streptococci produce
produce streptokinase
streptokinase
(
(fibrinolysin
fibrinolysin),
), substance
substance that
that activates
activates a
a proteolytic
proteolytic
enzyme
enzyme of
of plasma.
plasma. This
This enzyme,
enzyme, also
also called
called
fibrinolysin
fibrinolysin,
, is
is then
then able
able to
to dissolve
dissolve coagulated
coagulated plasma
plasma
and
and probably
probably aids in
aids in the
the spread
spread of
of streptococci
streptococci through
through
tissues
tissues.
. Streptokinase
Streptokinase is
is used
used in
in treatment
treatment of
of acute
acute
myocardial
myocardial infarction
infarction to
to dissolve
dissolve fibrin
fibrin clots
clots.
.
32. Enzymes
Enzymes
Hemolysins
Hemolysins and
and leukocidins
leukocidins
–
–Many
Many bacteria
bacteria produce
produce substances
substances that
that are
are
cytolysins
cytolysins -
- they
they dissolve
dissolve red
red blood
blood cells
cells
(
(hemolysins
hemolysins)
) or
or kill
kill tissue
tissue cells
cells or
or leukocytes
leukocytes
(
(hemolysins
hemolysins)
) or
or kill
kill tissue
tissue cells
cells or
or leukocytes
leukocytes
(
(leukocidins
leukocidins).
).
–
–Streptolysin
Streptolysin O,
O, for
for example
example,
, is
is produced
produced by
by
group
group A
A streptococci
streptococci and
and is
is letal
letal for
for mice
mice and
and
hemolytic
hemolytic for
for red
red blood
blood cells
cells from
from many
many
animals
animals.
.
33. Antiphagocytic
Antiphagocytic factors
factors
Many
Many bacterial
bacterial pathogens
pathogens are
are rapidly
rapidly killed
killed once
once they
they
are
are ingested
ingested by
by polymorphonuclear
polymorphonuclear cells
cells or
or
macrophages
macrophages.
.
Some
Some pathogens
pathogens evade
evade phagocytosis
phagocytosis or
or leukocyte
leukocyte
microbidical
microbidical mechanisms
mechanisms by
by adsorbing
adsorbing normal
normal host
host
microbidical
microbidical mechanisms
mechanisms by
by adsorbing
adsorbing normal
normal host
host
componets
componets to
to their
their surfaces
surfaces.
.
For
For example
example,
, Staphylococcus
Staphylococcus aureus
aureus has
has surface
surface
protein A,
protein A, which
which binds
binds to
to the
the Fc
Fc portion
portion of
of IgG
IgG.
. Other
Other
pathogens
pathogens have
have surface
surface factors
factors that
that impede
impede
phag
phago
ocytosis
cytosis e.g
e.g.
. Streptococcus
Streptococcus pneumoniae
pneumoniae and
and
many
many other
other bacteria
bacteria have
have polysaccharide
polysaccharide capsules
capsules.
.
34. Adherence
Adherence factors
factors
Once
Once bacteria
bacteria enter
enter the
the body
body of
of the
the host,
host, they
they
must
must adhere
adhere to
to cells
cells of
of a
a tissue
tissue surface
surface.
. If
If they
they
do not
do not adhere
adhere,
, they
they would
would be
be swept
swept away
away by
by
mucus
mucus and
and other
other fluids
fluids that
that bathe
bathe the
the tissue
tissue
surface
surface.
.
surface
surface.
.
Adherence (
Adherence (which
which is
is only
only one
one step in
step in the
the
infect
infecti
ious
ous process
process)
) is
is followed
followed by
by development
development
of
of microcolonies
microcolonies and
and subsequent
subsequent complex
complex
steps
steps in
in the
the pathogenesis
pathogenesis of
of infection
infection.
.
35. Adherence
Adherence factors
factors
The
The interactions
interactions between
between bacteria
bacteria and
and
tissue
tissue cell
cell surfaces
surfaces in
in the
the adhesion
adhesion
process
process are
are complex
complex.
.
Several
Several factors
factors play
play important
important role:
role:
–
–surface
surface hydrophobicity
hydrophobicity
–
–binding
binding molecules
molecules on
on bacteria
bacteria and
and host
host
cell receptor
cell receptor interaction
interaction
–
–and
and other
other